Company / Revenue per Share
Bio-Rad Laboratories Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$88.44
FY2025
5-year range
$86.17 / $96.82
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#24 of 153
Health Care
What the data says
Bio-Rad Laboratories's revenue per share of $88.44 is higher than 84% of companies in the Health Care sector (FY2025). Revenue per Share returned to growth in FY2025 after 3 years of decline, reaching $88.44.
Based on SEC 10-K filings.
88.44 in FY2025 with a 5-year CAGR of +3.1%. Top quartile in the Health Care sector.
Remained stable around $88.44 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -1.6%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 153This company $88.44 Sector average $123.62
▼
-28.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 2.6% year-over-year.
- Ranks #24 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.44 | +2.6% |
| FY2024 | $86.17 | -2.6% |
| FY2023 | $88.43 | -4.8% |
| FY2022 | $92.91 | -4.0% |
| FY2021 | $96.82 | +27.8% |
| FY2020 | $75.74 | -1.6% |
| FY2019 | $76.97 | +10.3% |
| FY2018 | $69.76 | +1.6% |
| FY2017 | $68.67 | -8.0% |
| FY2016 | $74.66 | +6.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026